C84.17
Sézary disease, spleen
Clinical Classification Guidelines
Medical Intelligence & Overview
Sézary disease is a rare form of cutaneous T-cell lymphoma characterized by the presence of malignant T-cells in the skin, blood, and lymphatic system. When the disease involves the spleen, it can indicate an advanced stage, affecting lymphatic function and overall health. This guide provides an overview of Sézary disease with spleen involvement, including its causes, symptoms, diagnosis, and general treatment considerations.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting T-cell regulation and proliferation. Abnormal immune responses leading to malignant T-cell development. Potential environmental factors, although specific triggers are not well-understood. History of other lymphoproliferative disorders may increase risk.
Key Symptoms: Persistent skin redness and thickening (erythroderma). Intense itching and skin discomfort. Presence of abnormal T-cells in the blood (Sézary cells). Lymphadenopathy (enlarged lymph nodes). Splenomegaly (enlarged spleen), leading to abdominal discomfort or fullness. Recurrent infections due to immune suppression. Fatigue, weight loss, or fever depending on disease progression.
Diagnostic & Treatment
Diagnosis Path: Comprehensive skin examination to assess extent of erythroderma. Blood tests showing increased Sézary cells (abnormal T-cells). Skin biopsies to confirm malignant T-cell presence. Imaging studies such as ultrasound, CT, or MRI to evaluate spleen size and involvement. Lymph node biopsies if lymphadenopathy is present. Flow cytometry and molecular tests to identify characteristic cell markers. Bone marrow examination may be performed to assess marrow infiltration.
Treatment Protocols: Skin-directed therapies such as topical corticosteroids, chemotherapy, and phototherapy. Systemic therapies including retinoids, interferons, or chemotherapy agents. Targeted biological therapies that focus on specific cell markers. Blood or marrow stem cell transplantation in selected cases. Supportive care to manage infections, skin care, and nutritional support. Monitoring for disease progression and adjusting treatment as needed.
Clinical Advice & FAQs
Billing Guidance
Is C84.17 a billable ICD-10 code?
Yes, C84.17 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.17?
Clinical documentation must specify the nature of Sézary disease, spleen and any associated comorbidities for accurate reporting.
Cite this Clinical Reference